IPOSchedule
EN
EnglishDeutschFrançais
2026 offering

WINDWARD BIO GROUP AG IPO

Windward Bio Group AG develops ultra-long-acting antibody medicines for serious respiratory and dermatologic diseases.

  • WWB
  • Nasdaq Global Market
  • Switzerland
  • Healthcare
Filed 23 Oct 2026

Offering in progress. A listing date has not been announced, and proposed terms may change.

Last verified 24 Oct 2026

Company overview

WINDWARD BIO GROUP AG website

Windward Bio Group AG is a clinical-stage biotechnology company. Its antibody medicines are being developed for conditions including asthma, COPD, and atopic dermatitis.

Company country
Switzerland

Offering details

USD · Base offering, before overallotment

Exchange
Nasdaq Global Market
Ticker
WWB

IPO timeline

  1. Registration filed

Filings and documents

Other IPO profiles

Industrials01

VME Companies

VME Companies provides engineering, procurement and construction services and modular process systems and equipment.

IPO valuation$276M – $345M
Filings Nasdaq Capital MarketIPO
Consumer discretionary02

Unitrend Entertainment Group

Unitrend Entertainment Group distributes television programs, co-produces audiovisual content and provides advertising services.

IPO valuation$185M – $231.3M
Filings Nasdaq Capital MarketIPO
Industrials03

Helio Corp /FL/

Helio Corporation is a holding company providing technology, engineering, and research and development services.

Listing valuation$29.5M – $36.8M
Filings Nasdaq Capital MarketUplisting